BLTE Smart Money
Belite Bio, Inc
1W: -2.7%
1M: -14.3%
3M: -8.1%
YTD: -10.0%
1Y: +55.4%
3Y: +343.1%
$145.72
+2.37 (+1.65%)
After Hours: $148.58 (+2.86, +1.96%)
Weekly Expected Move ±6.0%
$130
$138
$147
$156
$165
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' 57.62.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
🏦 Institutional Activity
Latest: Q2 202698
Institutions Holding
+2 vs prior
24.7%
Ownership
+0.83%
23
New
28
Increased
38
Reduced
16
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Scholl Hendrik Peter | officer: chief medical officer | S-Sale | 2 | $170.02 | $340 | Filing |
| 2026-10-01 | Scholl Hendrik Peter | officer: chief medical officer | S-Sale | 14 | $169.36 | $2K | Filing |
| 2026-10-01 | Scholl Hendrik Peter | officer: chief medical officer | S-Sale | 12 | $168.21 | $2K | Filing |
| 2026-10-01 | Scholl Hendrik Peter | officer: chief medical officer | S-Sale | 78 | $167.59 | $13K | Filing |
| 2026-10-01 | Scholl Hendrik Peter | officer: chief medical officer | S-Sale | 50 | $166.44 | $8K | Filing |
| 2026-10-01 | Scholl Hendrik Peter | officer: chief medical officer | S-Sale | 120 | $165.49 | $20K | Filing |
| 2026-10-01 | Scholl Hendrik Peter | officer: chief medical officer | S-Sale | 24 | $164.64 | $4K | Filing |
| 2026-10-01 | Scholl Hendrik Peter | officer: chief medical officer | S-Sale | 200 | $163.62 | $33K | Filing |
| 2026-09-08 | Chuang Hao-Yuan | officer: chief financial officer | S-Sale | 2,200 | $194.28 | $427K | Filing |
| 2026-09-08 | Lin Yu-Hsin | officer: chief executive officer | S-Sale | 8,752 | $197.36 | $1.7M | Filing |
| 2026-09-08 | Lin Yu-Hsin | officer: chief executive officer | S-Sale | 2,700 | $198.09 | $535K | Filing |
| 2026-09-08 | Chuang Hao-Yuan | officer: chief financial officer | S-Sale | 4,120 | $195.60 | $806K | Filing |
| 2026-09-08 | Chuang Hao-Yuan | officer: chief financial officer | S-Sale | 4,475 | $196.47 | $879K | Filing |
| 2026-09-08 | Chuang Hao-Yuan | officer: chief financial officer | S-Sale | 4,605 | $197.23 | $908K | Filing |
| 2026-09-08 | Chuang Hao-Yuan | officer: chief financial officer | S-Sale | 2,562 | $198.05 | $507K | Filing |
| 2026-09-08 | Lin Yu-Hsin | officer: chief executive officer | S-Sale | 6,058 | $196.54 | $1.2M | Filing |
| 2026-09-08 | Lin Yu-Hsin | officer: chief executive officer | S-Sale | 6,090 | $195.62 | $1.2M | Filing |
| 2026-09-08 | Lin Yu-Hsin | officer: chief executive officer | S-Sale | 2,400 | $194.33 | $466K | Filing |
| 2026-09-04 | Chuang Hao-Yuan | officer: chief financial officer | S-Sale | 3,759 | $183.27 | $689K | Filing |
| 2026-09-04 | Lin Yu-Hsin | officer: chief executive officer | S-Sale | 600 | $190.39 | $114K | Filing |
| 2026-09-04 | Lin Yu-Hsin | officer: chief executive officer | S-Sale | 8,111 | $193.13 | $1.6M | Filing |
| 2026-09-04 | Lin Yu-Hsin | officer: chief executive officer | S-Sale | 4,209 | $192.54 | $810K | Filing |
| 2026-09-04 | Lin Yu-Hsin | officer: chief executive officer | S-Sale | 11,080 | $191.15 | $2.1M | Filing |
| 2026-09-04 | Lin Yu-Hsin | officer: chief executive officer | S-Sale | 4,593 | $185.34 | $851K | Filing |
| 2026-09-04 | Lin Yu-Hsin | officer: chief executive officer | S-Sale | 6,252 | $184.52 | $1.2M | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | 3,077,219 | $457M | +19,807 | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 1,232,877 | $190M | +118,093 | 2026-06-30 | Filing |
| RTW INVESTMENTS, LP | 715,332 | $110M | — | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 494,564 | $76M | -75,524 | 2026-06-30 | Filing |
| MAVERICK CAPITAL LTD | 396,311 | $61M | +396,311 | 2026-06-30 | Filing |
| EVENTIDE ASSET MANAGEMENT, LLC | 390,829 | $60M | +33,179 | 2026-06-30 | Filing |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 357,199 | $55M | +53,186 | 2026-06-30 | Filing |
| Holocene Advisors, LP | 251,035 | $39M | -243,460 | 2026-06-30 | Filing |
| Logos Global Management LP | 250,000 | $38M | +250,000 | 2026-06-30 | Filing |
| MORGAN STANLEY | 235,071 | $36M | +33,662 | 2026-06-30 | Filing |
| UBS Group AG | 224,989 | $35M | -543,370 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 186,168 | $29M | +184,160 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 166,188 | $26M | +60,679 | 2026-06-30 | Filing |
| Affinity Asset Advisors, LLC | 165,000 | $25M | +100,000 | 2026-06-30 | Filing |
| MPM BIOIMPACT LLC | 137,208 | $21M | +49,163 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 124,783 | $19M | +121,005 | 2026-06-30 | Filing |
| Patient Square Capital LP | 110,000 | $17M | -6,684 | 2026-06-30 | Filing |
| Duquesne Family Office LLC | 106,100 | $16M | — | 2026-06-30 | Filing |
| JANE STREET GROUP, LLC | 65,801 | $10M | +53,579 | 2026-06-30 | Filing |
| BNP PARIBAS FINANCIAL MARKETS | 57,125 | $9M | +24,600 | 2026-06-30 | Filing |